Abstract Title:

[Sdudy on effect of tripterygium on plasma IL-18 content in patients with lupus nephritis].

Abstract Source:

Zhongguo Zhong Yao Za Zhi. 2008 May;33(9):1075-7. PMID: 18652362

Abstract Author(s):

Cai-Yun Jin, Guo-Hua Hu, Bi-Zhong Zheng, Dong-Lian Wang

Abstract:

OBJECTIVE: It is to study the effect of tripterygium (TW) on the plasma IL-18 content in patients with lupus nephritis (LN) and its treatment value. METHOD: The patients with LN treated with prednisone were divided into active groupand inactive group with active index. The active group was given tripterygium additionally. The changing of plasma IL-18 and release of nephritis were observed after treatment for three months. RESULT: The level of plasma IL-18 lowered down obviously, urinary protein decreased, LN activity index, hematuria and renal function improved. CONCLUSION: Tripterygium caninhibitroduction of plasma IL-18. It has definite treatment value on controlling LN activity.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.